Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,996,650
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
17,724,839
-
Shares change
-
+17,724,839
-
Total reported value, excl. options
-
$401,085,000
-
Value change
-
+$401,084,714
-
Number of buys
-
32
-
Price
-
$22.77
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q2 2021
32 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q2 2021.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,724,839 shares
of 101,996,650 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4,965,588 shares), FMR LLC (2,312,450 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,505,396 shares), VIKING GLOBAL INVESTORS LP (1,341,396 shares), JANUS HENDERSON GROUP PLC (1,297,770 shares), BOXER CAPITAL, LLC (1,189,943 shares), BVF INC/IL (918,975 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (818,980 shares), PERCEPTIVE ADVISORS LLC (756,047 shares), and VANGUARD GROUP INC (619,384 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.